Cash, cash equivalents, and marketable securities were $500.9 million as of June 30, 2024, which are expected to fund our operational plans well into 2027.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRON:
- Disc Medicine Reports Second Quarter 2024 Financial Results and Provides Business Update
- Is IRON a Buy, Before Earnings?
- Disc Medicine closes up 18% to $46.27 after data, stock offering
- Disc Medicine jumps 18% to $46.15 after data update, share offering
- Disc Medicine price target raised to $70 from $50 at BMO Capital